...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Optical resolution by preferential crystallization of (1RS,3RS)-1,2,3,4-tetrahydro-6,7-dihydroxy-1-methyl-3-isoquinolinecarboxyl ic acid.
【24h】

Optical resolution by preferential crystallization of (1RS,3RS)-1,2,3,4-tetrahydro-6,7-dihydroxy-1-methyl-3-isoquinolinecarboxyl ic acid.

机译:通过优先结晶(1RS,3RS)-1,2,3,4-四氢-6,7-二羟基-1-甲基-3-异喹啉羧酸的光学拆分。

获取原文
获取原文并翻译 | 示例
           

摘要

The racemic structure of (1RS,3RS)-1,2,3,4-tetrahydro-6,7-dihydroxy-1-methyl-3-isoquinolinecarboxyl ic acid [(1RS,3RS)-1] was examined based on the melting point, solubility, and IR spectrum, with the aim of optical resolution by preferential crystallization. (1RS,3RS)-1 was indicated from these results to exist as a conglomerate. The successive optical resolution by preferential crystallization of (1RS,3RS)-1 yielded (1S,3S)- and (1R,3R)-1 with optical purities of 85--95% at 66--81% degrees of resolution, which were fully purified by recrystallization.
机译:基于熔融,检查了(1RS,3RS)-1,2,3,4-四氢-6,7-二羟基-1-甲基-3-异喹啉羧酸[[(1RS,3RS)-1]的外消旋结构。点,溶解度和IR光谱,目的是通过优先结晶获得光学分辨率。这些结果表明(1RS,3RS)-1以集团形式存在。通过优先结晶(1RS,3RS)-1进行的连续光学拆分产生了(1S,3S)-和(1R,3R)-1,在66--81%的拆分度下其光学纯度为85--95%,通过重结晶完全纯化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号